Kamila Pawlicka

Kamila Pawlicka is a Senior Scientist at Carcinotech Ltd with expertise in optimisation of 3D cell culture assays and drug testing. Previously, Kamila was a PhD student at The University of Edinburgh, focusing on proteogenomics platforms for personalized neoantigen therapeutics in cancer. As a research assistant at Institute of Bioorganic Chemistry PAS, Kamila investigated the role of JMJD3 histone demethylase in cancer and aging. Kamila's educational background includes a PhD in Precision Medicine DTP, a Master's degree in Medical Biotechnology, and a Bachelor's degree in Medical biotechnology.